| Identification | Back Directory | [Name]
Propanoic acid, 3-[{3,3-dibutyl-2,3,4,5-tetrahydro-7-(methylthio)-1,1-dioxido-5-phenyl-1,2,5-benzothiadiazepin-8-yl}oxy]- | [CAS]
2460667-52-9 | [Synonyms]
Ritivixibat
Propanoic acid, 3-[{3,3-dibutyl-2,3,4,5-tetrahydro-7-(methylthio)-1,1-dioxido-5-phenyl-1,2,5-benzothiadiazepin-8-yl}oxy]- | [Molecular Formula]
C26H36N2O5S2 | [MOL File]
2460667-52-9.mol | [Molecular Weight]
520.7 |
| Hazard Information | Back Directory | [Uses]
Ritivixibat is an inhibitor of ileal bile acid transporter (IBAT), as well as a bile acid modulator. Ritivixibat can be used for research of cardiovascular diseases, fatty acid metabolism and glucose utilization disorders, gastrointestinal diseases and liver diseases[1][2]. | [References]
[1] Gillberg Per-Goeran, et al. Preparation of benzothiazepines as liver bile acid transport inhibitors for the treatment of liver, gastrointestinal and other disorders: United States, US20200247769. 2020-08-06.
[2] WHO Drug Information-World Health Organization (WHO). |
|
|